VISIPAQUE sol inj 270 mg/ml 10 fl PP 100 ml
7680522284176
CH-52228
V08AB09
14.01.0.
1 / 3
google
Details
- Product number
- 5222802
- CPT
- -
- Packaging group
- 10 x 100
- Unit
- ml
- Composition
- iodixanolum 550 mg corresp. iodum 270 mg, trometamolum, natrii calcii edetas, calcii chloridum dihydricum, natrii chloridum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.76 mg.
Articles (1)
Visipaque 270 mg/mL, Injektionslösung
Injektionslösung
10 x 100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
550.0 MG | Substance | WIZUS |
|
(N/A)
|
270.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.76 MG | Substance | HBESI |
Authorization holder
GE Healthcare AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 52228
- Drug name
- Visipaque, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- V08AB09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 15/04/1994
- Authorization expiration date
- 31/12/9999
- IT number
- 14.01.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VISIPAQUE sol inj 270 mg/ml 10 fl PP 100 ml
- Description (DE)
- VISIPAQUE Inj Lös 270 mg/ml 10 PP Fl 100 ml
- Market launch
- 15/04/1994
- Narcotic (BTM)
- No